Marijuana Reform
Beginning with California in 1996, DPA has played a pivotal role in roughly half of the campaigns that have legalized medical marijuana in the U.S.
We’re also the only organization that played a role in all the victorious campaigns to legalize marijuana more broadly to date – Colorado and Washington in 2012, Uruguay in 2013, and Oregon, Alaska and Washington, D.C., in 2014, and California, Massachusetts, Maine and Nevada in 2016.
Now almost 200 million Americans live in medical marijuana states and more than 60 million live in states where marijuana prohibition is a thing of the past.
2007 – New Mexico Legalizes Medical Marijuana
In 2007, following a multi-year campaign led by DPA, New Mexico became the first state to pass a medical marijuana law requiring a state production and distribution system. Since then, DPA has won several improvements to the program and fought off multiple legislative efforts to repeal this groundbreaking law.
2011 – New Jersey Legalizes Medical Marijuana
New Jersey Governor Chris Christie green-lighted implementation of the state’s medical marijuana legislation in July 2011 after delaying it over concerns about federal interference. DPA’s New Jersey office spearheaded an effort to urge the governor to move forward with the program and protect patients.
2012 – Colorado and Washington Legalize Marijuana
Colorado and Washington made history by becoming the first states to legalize marijuana in 2012, and Colorado became the first state to offer legal retail sales of marijuana in January 2014. The Drug Policy Alliance and its electoral arm, Drug Policy Action, worked closely with local and national allies to draft these ballot initiatives, build coalitions and raise funds.
2013 – Uruguay Legalizes Marijuana
On December 10, 2013, Uruguay became the first country in the world to legally regulate the production, distribution and sale of marijuana for adults. DPA was deeply involved in efforts to legalize marijuana in Uruguay. Our policy manager for the Americas, Hannah Hetzer, spent nine months in Uruguay working with a diverse coalition of Uruguayan civil society organizations on a public education campaign that included input from political consultants and activists in the U.S. who had worked on the successful campaigns in Colorado and Washington.
2014 – Oregon, D.C. and Alaska Legalize Marijuana
On Election Day in November 2014, Oregon and Alaska voters made their states the third and fourth in the nation to legally regulate the production, distribution and sale of marijuana. DPA’s sister organization, Drug Policy Action, was the single largest donor to the Oregon campaign and was deeply involved in the measure’s drafting and on-the-ground campaign. The Drug Policy Alliance and Drug Policy Action also played a leadership role and provided significant financial assistance for Washington, D.C.’s successful campaign.
2014 – New York Legalizes Medical Marijuana
In June 2014, New York became the 23rd state with a medical marijuana law. DPA's New York policy office worked with allies across the state to bring the voices of patients, providers and caregivers to the legislature and governor's office. The bill passed and was signed despite significant opposition from leaders in Albany.
2016 – California Sets New Gold Standard for Marijuana Legalization
In the 2016 election, California, Maine, Massachusetts, and Nevada legalized marijuana, while medical marijuana initiatives prevailed in Arkansas, Florida, Montana and North Dakota. DPA was involved in virtually all of these efforts, helping with drafting, funding and advocacy. The most significant of these victories was California’s Proposition 64, which legalizes the adult use of marijuana in the nation’s largest state. It enacts across-the-board retroactive sentencing reform for marijuana offenses, while establishing a comprehensive system to tax and regulate businesses to produce and distribute marijuana in a legal market. Prop. 64 sets a new gold standard for marijuana policy because of its cutting edge provisions to undo the most egregious harms of marijuana prohibition on impacted communities of color and the environment as well as its sensible approaches to public health, youth protection, licensing and revenue allocation. The Drug Policy Alliance and its lobbying arm, Drug Policy Action, played a key leadership role in the California campaign—co-drafting the initiative, coordinating the political mobilization, social media, public relations and more, and raising over $5 million to fund the effort.
Learn more about our work to reform marijuana laws.
Criminal Justice Reform
DPA has been at the forefront of many, perhaps most, major drug sentencing reforms over the past two decades. There are many tens of thousands fewer people behind bars today as a result of DPA’s efforts—and hundreds of thousands who either did not go to jail or prison, or who spent less time there, because of our work.
2000 – California Passes Proposition 36
California’s landmark treatment-not-incarceration law, Proposition 36, was approved via ballot initiatives by 61 percent of California voters in November 2000. Prop. 36 allowed first- and second-time nonviolent drug offenders the opportunity to receive substance abuse treatment instead of jail time. DPA was the proponent of this initiative and led the campaign. Since 2000, Prop 36 has save California billions of dollars on prison expenditures, while diverting hundreds of thousands of people arrested for drug possession from incarceration.
2010 – Federal Fair Sentencing Act Signed Into Law
DPA played a crucial role in the 2010 passage of the federal Fair Sentencing Act, which reduced the crack/powder sentencing disparity and repealed a mandatory minimum sentence for the first time since 1970.
2010 – New York Reforms the Rockefeller Drug Laws
DPA spearheaded the successful campaign to enact major reforms of New York’s notorious Rockefeller Drug Laws. The reforms, signed into law by Gov. David Paterson in 2010, included eliminating mandatory minimum sentences and returning judicial discretion in many drug cases; reforming the state’s sentencing structure; expanding drug treatment and alternatives to incarceration; and allowing resentencing of people serving sentences under the old laws.
2012 – California Reforms “Three Strikes Law”
On Election Day in November 2012, Californians passed Proposition 36, which reformed California’s notorious Three Strikes Law so no more Californians would be sentenced to life in prison for minor and nonviolent drug law offenses. The Drug Policy Alliance’s electoral arm, Drug Policy Alliance Issues PAC, was one of the primary financial contributors to the Prop. 36 campaign.
2014 – California Scales Back Mass Incarceration
Californians overwhelmingly voted in favor of Proposition 47, which changes six low-level, nonviolent offenses – including simple drug possession – from felonies to misdemeanors. DPA’s lobbying arm, Drug Policy Action, supported this initiative with assistance on its drafting, as well as financial and other support for the campaign.
2014 – New Jersey Approves Bail Reform
New Jersey voters approved a ballot measure to reform New Jersey’s bail system in November 2014. The new law allowed judges to deny bail to dangerous individuals. Now pretrial release decisions are made based on risk rather than resources and thousands of low-income individuals – many of whom are behind bars for a low-level drug law violation – will avoid unnecessary jail time. The Drug Policy Alliance and Drug Policy Action played a leading role in efforts to pass both this legislation and the accompanying ballot initiative.
2015-16 – California, Florida and New Mexico Pass Groundbreaking Asset Forfeiture Reforms
In 2015, DPA led a successful effort to pass legislation that eliminated civil asset forfeiture in New Mexico. We followed this up in 2016 by successfully campaigning for California and Florida to reform their civil asset forfeiture laws to protect people suspected of drug law violations from unjust property seizures.
Learn more about our work to oppose drug war injustice.
Harm Reduction
DPA is leading the fight to reduce the death, disease, crime and suffering associated with both drug use and drug prohibition.
Syringe Access
Throughout DPA’s history, one major focus has been reducing the spread of HIV/AIDS, hepatitis C and other preventable diseases by making sterile syringes legally available. DPA played a pivotal role in successful efforts to make syringes legally available in New York (2000), California (2004), and New Jersey (2006) and supported successful efforts in Connecticut, Illinois and other states.
More recently, we led a successful effort in Congress to overturn the decades-long ban on federal funding for syringe access programs, and played a key role in passing legislative reforms in Florida (2016) and Indiana (2015) to initiate such programs.
Overdose Prevention
DPA took the lead over a decade ago in addressing the rapidly growing number of overdose deaths, which recently surpassed auto accidents as the leading cause of accidental death in the U.S. The past few years have been transformative for overdose prevention efforts in the U.S., and much of it can be credited to our efforts.
Since 2010, than three dozen states have passed legislation to increase access to naloxone and “911 Good Samaritan” laws to stop arresting and prosecuting people for drug possession when they call 911 to report an overdose. DPA was responsible for the passage of 911 Good Samaritan laws in New Jersey, California and New York, as well as the first 911 Good Samaritan law in the U.S., which was passed in New Mexico in 2007. We have also played an instrumental role in the passage of numerous naloxone access laws, including successful efforts in California and New York to make it available over-the-counter.
Learn more about our harm reduction work.